| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 777 | 2.577 | 16.431 | 6.718 | 0 | 0 | 0 | 0 | 41.612 |
| Total Income - EUR | - | 777 | 2.577 | 16.431 | 6.718 | 0 | 0 | 0 | 0 | 41.638 |
| Total Expenses - EUR | - | 1.366 | 16.047 | 13.289 | 6.153 | 173 | 0 | 61 | 0 | 18.063 |
| Gross Profit/Loss - EUR | - | -589 | -13.471 | 3.142 | 565 | -173 | 0 | -61 | 0 | 23.575 |
| Net Profit/Loss - EUR | - | -612 | -13.535 | 2.977 | 490 | -173 | 0 | -61 | 0 | 20.059 |
| Employees | - | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Derma Tube S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 925 |
| Current Assets | - | 212 | 2.054 | 574 | 1.288 | 1.150 | 1.124 | 1.117 | 1.175 | 12.139 |
| Inventories | - | 149 | 1.927 | 471 | 882 | 865 | 846 | 848 | 907 | 1.102 |
| Receivables | - | 0 | 0 | 0 | 274 | 269 | 263 | 264 | 263 | 10.298 |
| Cash | - | 63 | 128 | 103 | 132 | 16 | 16 | 5 | 5 | 738 |
| Shareholders Funds | - | -567 | -14.093 | -10.857 | -10.157 | -10.138 | -9.913 | -10.005 | -9.914 | 10.201 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 780 | 16.147 | 11.431 | 11.445 | 11.288 | 11.037 | 11.122 | 11.089 | 2.863 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Derma Tube S.r.l.